A bill to encourage the manufacture of active pharmaceutical ingredients in America was introduced in the U.S. Senate Tuesday by Senators Marsha Blackburn (R- TN) and Bob Menendez (R- NJ). It was read and referred to the Committee on Health, Education, Labor, and Pensions.
The “Securing America’s Medicine Cabinet Act” (SAM-C), S. 3432, expands the FDA’s Emerging Technology Program and authorizes $100 million to develop centers of excellence for advanced pharmaceutical manufacturing to help not only develop, but manufacture, therapeutics in the U.S.
